Divis Laboratories Ltd | DIVI - Gross Profit On Sales

Stock Price
5,888.50
Daily Change
38.50 0.66%
Monthly
-6.97%
Yearly
9.33%
Q2 Forecast
5,728.83

Divis Laboratories Ltd reported INR16.59B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Aurobindo Pharma INR 51.23B 1.76B Dec/2025
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Lupin INR 49.76B 704.6M Dec/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 57.47M 10.16M Jun/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 72.15M 8.77M Dec/2025